Readline

About:

Readline is a biological immobilized enzyme catalysis technology application service provider.

Website: https://www.szreadline.com/

Top Investors: Co-Stone Venture Capital, Gree Electric Appliance, Oriental Fortune Capital, Xinshang Capital, Leaguer Group

Description:

Readline is a bio-pharmaceutical high-tech company with a multidisciplinary application based on enzyme catalysis technology. It is the world's first company to use directed evolution of enzymes in the large-scale production of API such as peptides, carbohydrate, and nucleic acids on an all-green basis. These APIs are primarily used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers, and other applications.

Total Funding Amount:

400M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shenzhen, Guangdong, China

Founded Date:

2017-08-28

Contact Email:

sales(AT)szreadline.com

Founders:

Jian Liu

Number of Employees:

251-500

Last Funding Date:

2023-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai